Query
Search
Aggregations
IP Type
Patent
5
Trademark
4
Jurisdiction
United States
5
Canada
2
Europe
2
Date
2024
1
2023
1
Before 2020
7
IPC Class
A61K 39/12 - Viral antigens
5
A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
5
A61K 9/00 - Medicinal preparations characterised by special physical form
5
A61K 39/00 - Medicinal preparations containing antigens or antibodies
4
A61K 39/17 - Newcastle disease virus
4
A61K 39/215 - Coronaviridae, e.g. avian infectious bronchitis virus
4
A61K 39/255 - Marek's disease virus
4
A61K 39/275 - Poxviridae, e.g. avipoxvirus
4
A61K 9/20 - Pills, lozenges or tablets
4
A61K 9/46 - Pills, lozenges or tablets effervescent
4
A61P 37/04 - Immunostimulants
1
See more
See less
Status
Pending
2
Registered / In Force
7
1.
REDUCED FOAMING VACCINE COMPOSITIONS
Application Number
18483149
Status
Pending
Filing Date
2023-10-09
First Publication Date
2024-02-08
Owner
Abic Biological Laboratories Ltd. (Israel)
Inventor
Genin, Noel Yves Henri Jean
Abstract
The present invention relates to novel stable compressed vaccine composition comprising at least one anhydrous antigenic component comprising a stabilizer susceptible to foaming when the composition is mixed with liquid diluent; and an effective amount of a sugar alcohol.
IPC Classes ?
A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
A61K 9/46 - Pills, lozenges or tablets effervescent
A61K 39/12 - Viral antigens
A61K 9/20 - Pills, lozenges or tablets
A61K 39/00 - Medicinal preparations containing antigens or antibodies
A61K 39/255 - Marek's disease virus
A61K 39/275 - Poxviridae, e.g. avipoxvirus
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 39/17 - Newcastle disease virus
A61K 39/215 - Coronaviridae, e.g. avian infectious bronchitis virus
2.
TABIC
Serial Number
97742695
Status
Pending
Filing Date
2023-01-05
Owner
Abic Biological Laboratories Ltd. (Israel)
NICE Classes ?
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Vaccines in fast dissolved compacted solid form; Veterinary vaccines; Poultry vaccines
3.
Methods of making solid vaccine compositions having reduced foaming
Application Number
16256463
Grant Number
10610596
Status
In Force
Filing Date
2019-01-24
First Publication Date
2019-05-23
Grant Date
2020-04-07
Owner
Abic Biological Laboratories Ltd. (Israel)
Inventor
Genin, Noel Yves Henri Jean
Abstract
Disclosed and claimed are methods for making solid vaccine compositions that have reduced foaming when mixed with liquid diluent. The methods include mixing an effective amount of a foam controlling agent with at least one anhydrous antigenic component, a stabilizer, and an effervescent agent. The foam controlling agent is a sugar alcohol, such as mannitol. The effective amount of sugar alcohol is about 15% to about 40% by weight of the solid vaccine composition. And, upon adding a diluent to the solid vaccine composition, the effervescent agent reacts to form gas in situ, and foam resulting from the gas is reduced.
IPC Classes ?
A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
A61K 9/46 - Pills, lozenges or tablets effervescent
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 9/20 - Pills, lozenges or tablets
A61K 39/00 - Medicinal preparations containing antigens or antibodies
A61K 39/12 - Viral antigens
A61K 39/17 - Newcastle disease virus
A61K 39/215 - Coronaviridae, e.g. avian infectious bronchitis virus
A61K 39/255 - Marek's disease virus
A61K 39/275 - Poxviridae, e.g. avipoxvirus
4.
Reduced foaming vaccine compositions
Application Number
16125911
Grant Number
10213509
Status
In Force
Filing Date
2018-09-10
First Publication Date
2019-01-03
Grant Date
2019-02-26
Owner
ABIC BIOLOGICAL LABORATORIES LTD. (Israel)
Inventor
Genin, Noel Yves Henri Jean
Abstract
The present invention relates to novel stable compressed vaccine composition comprising at least one anhydrous antigenic component comprising a stabilizer susceptible to foaming when the composition is mixed with liquid diluent; and an effective amount of a sugar alcohol.
IPC Classes ?
A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
A61K 9/46 - Pills, lozenges or tablets effervescent
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 39/00 - Medicinal preparations containing antigens or antibodies
A61K 39/12 - Viral antigens
A61K 39/17 - Newcastle disease virus
A61K 39/215 - Coronaviridae, e.g. avian infectious bronchitis virus
A61K 39/255 - Marek's disease virus
A61K 39/275 - Poxviridae, e.g. avipoxvirus
A61K 9/20 - Pills, lozenges or tablets
5.
Reduced foaming vaccine compositions
Application Number
14880145
Grant Number
10188734
Status
In Force
Filing Date
2015-10-09
First Publication Date
2016-09-08
Grant Date
2019-01-29
Owner
ABIC BIOLOGICAL LABORATORIES LTD. (Israel)
Inventor
Genin, Noel Yves Henri Jean
Abstract
The present invention relates to novel stable compressed vaccine composition comprising at least one anhydrous antigenic component comprising a stabilizer susceptible to foaming when the composition is mixed with liquid diluent; and an effective amount of a sugar alcohol.
IPC Classes ?
A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
A61K 39/00 - Medicinal preparations containing antigens or antibodies
A61K 39/12 - Viral antigens
A61K 39/17 - Newcastle disease virus
A61K 39/215 - Coronaviridae, e.g. avian infectious bronchitis virus
A61K 39/255 - Marek's disease virus
A61K 39/275 - Poxviridae, e.g. avipoxvirus
A61K 9/20 - Pills, lozenges or tablets
A61K 9/46 - Pills, lozenges or tablets effervescent
A61K 9/00 - Medicinal preparations characterised by special physical form
6.
REDUCED FOAMING VACCINE COMPOSITIONS
Document Number
02964171
Status
In Force
Filing Date
2015-10-09
Open to Public Date
2016-04-14
Grant Date
2023-03-28
Owner
ABIC BIOLOGICAL LABORATORIES LTD. (Israel)
Inventor
Genin, Noel Yves Henri Jean
Abstract
The present invention relates to novel stable compressed vaccine composition comprising at least one anhydrous antigenic component comprising a stabilizer susceptible to foaming when the composition is mixed with liquid diluent; and an effective amount of a sugar alcohol.
IPC Classes ?
A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 39/12 - Viral antigens
A61P 37/04 - Immunostimulants
7.
TABIC
Application Number
122231600
Status
Registered
Filing Date
2004-06-30
Registration Date
2005-09-01
Owner
ABIC BIOLOGICAL LABORATORIES LTD. (Israel)
NICE Classes ?
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
(1) Vaccines in fast dissolved compacted solid form for the immunization of poultry.
8.
TABIC
Application Number
003174182
Status
Registered
Filing Date
2003-05-19
Registration Date
2004-10-29
Owner
Abic Biological Laboratories Ltd (Israel)
NICE Classes ?
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Vaccines in fast dissolved compacted solid form for veterinary use only.
9.
BROMOSEPT
Application Number
000115634
Status
Registered
Filing Date
1996-04-01
Registration Date
1998-07-09
Owner
Abic Biological Laboratories Ltd (Israel)
NICE Classes ?
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Pharmaceutical and veterinary preparations; disinfectants; sanitary preparations.